ShockWave Medical Inc
Company Overview
ShockWave Medical, Inc. is a medical device company focused on developing and commercializing products intended to transform the treatment of calcified cardiovascular disease. The company has developed and is commercializing intravascular lithotripsy (IVL) technology, which is an approach to calcium modification that uses sonic pressure waves.
Their primary products include the ShockWave IVL System with the ShockWave C2 Coronary IVL Catheter and ShockWave M5 and S4 Peripheral IVL Catheters, which are designed to treat calcified plaque in patients with peripheral vascular, coronary vascular and heart valve disease.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| March 31, 2024 | $218.81m | $179.34m | - | $2.94m | 0.00% | 1.64% |
| Dec. 31, 2023 | $202.98m | $162.65m | - | $2.95m | 0.00% | 1.81% |
| Sept. 30, 2023 | $186.02m | $144.91m | - | $2.51m | 0.00% | 1.73% |
Company Impact
Help us evaluate ShockWave Medical Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.